125 related articles for article (PubMed ID: 33813046)
21. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
[TBL] [Abstract][Full Text] [Related]
22. Lack of association between COMT gene and deficit/nondeficit schizophrenia.
Wonodi I; Mitchell BD; Stine OC; Hong LE; Elliott A; Kirkpatrick B; Carpenter WT; Thaker GK; Buchanan RW
Behav Brain Funct; 2006 Dec; 2():42. PubMed ID: 17173666
[TBL] [Abstract][Full Text] [Related]
23. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
[TBL] [Abstract][Full Text] [Related]
24. Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia.
Horan WP; Blanchard JJ
Schizophr Res; 2003 Dec; 65(2-3):125-37. PubMed ID: 14630305
[TBL] [Abstract][Full Text] [Related]
25. Primary, Enduring Negative Symptoms: An Update on Research.
Kirkpatrick B; Mucci A; Galderisi S
Schizophr Bull; 2017 Jul; 43(4):730-736. PubMed ID: 28575513
[TBL] [Abstract][Full Text] [Related]
26. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis.
González-Blanco L; García-Portilla MP; Gutiérrez M; Mezquida G; Cuesta MJ; Urbiola E; Amoretti S; Barcones F; González-Pinto A; Pina-Camacho L; Corripio I; Vieta E; Baeza I; Toll A; Sáiz PA; Bobes J; Bernardo M;
Schizophr Res; 2021 Oct; 236():19-28. PubMed ID: 34365082
[TBL] [Abstract][Full Text] [Related]
27. Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin.
Wang X; Yao S; Kirkpatrick B; Shi C; Yi J
Psychiatry Res; 2008 Mar; 158(2):195-205. PubMed ID: 18243336
[TBL] [Abstract][Full Text] [Related]
28. [The Relationship of Deficit Syndrome with Clinical Symptoms, Summer Births and Heritability in Patients with Schizophrenia].
Mete L; Sarıkaya Ö; Erol A
Turk Psikiyatri Derg; 2015; 26(4):229-35. PubMed ID: 26731019
[TBL] [Abstract][Full Text] [Related]
29. Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia.
Thibaut F; Ribeyre JM; Dourmap N; Ménard JF; Dollfus S; Petit M
Biol Psychiatry; 1998 Jan; 43(1):24-30. PubMed ID: 9442341
[TBL] [Abstract][Full Text] [Related]
30. Differences in glucose tolerance between deficit and nondeficit schizophrenia.
Kirkpatrick B; Fernandez-Egea E; Garcia-Rizo C; Bernardo M
Schizophr Res; 2009 Feb; 107(2-3):122-7. PubMed ID: 19046857
[TBL] [Abstract][Full Text] [Related]
31. Attentional impairments in deficit and nondeficit forms of schizophrenia.
Buchanan RW; Strauss ME; Breier A; Kirkpatrick B; Carpenter WT
Am J Psychiatry; 1997 Mar; 154(3):363-70. PubMed ID: 9054784
[TBL] [Abstract][Full Text] [Related]
32. Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis.
Wheeler AL; Wessa M; Szeszko PR; Foussias G; Chakravarty MM; Lerch JP; DeRosse P; Remington G; Mulsant BH; Linke J; Malhotra AK; Voineskos AN
JAMA Psychiatry; 2015 May; 72(5):446-55. PubMed ID: 25786193
[TBL] [Abstract][Full Text] [Related]
33. Cannabis use and family history in adolescent first episode psychosis in Durban, South Africa.
Paruk S; Burns JK; Caplan R
J Child Adolesc Ment Health; 2013; 25(1):61-8. PubMed ID: 25860308
[TBL] [Abstract][Full Text] [Related]
34. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.
Quattrone D; Reininghaus U; Richards AL; Tripoli G; Ferraro L; Quattrone A; Marino P; Rodriguez V; Spinazzola E; Gayer-Anderson C; Jongsma HE; Jones PB; La Cascia C; La Barbera D; Tarricone I; Bonora E; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Arrojo M; Tortelli A; Velthorst E; Berendsen S; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Kirkbride JB; Sham PC; O'Donovan MC; Cardno AG; Vassos E; van Os J; Morgan C; Murray RM; Lewis CM; Di Forti M;
Transl Psychiatry; 2021 Aug; 11(1):423. PubMed ID: 34376640
[TBL] [Abstract][Full Text] [Related]
35. Depressive symptoms and the deficit syndrome of schizophrenia.
Kirkpatrick B; Buchanan RW; Breier A; Carpenter WT
J Nerv Ment Dis; 1994 Aug; 182(8):452-5. PubMed ID: 8040655
[TBL] [Abstract][Full Text] [Related]
36. The relation of basic self-disturbance to self-harm, eating disorder symptomatology and other clinical features: Exploration in an early psychosis sample.
Rasmussen AR; Reich D; Lavoie S; Li E; Hartmann JA; McHugh M; Whitford TJ; Nelson B
Early Interv Psychiatry; 2020 Jun; 14(3):275-282. PubMed ID: 31264785
[TBL] [Abstract][Full Text] [Related]
37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
38. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
Quattrone D; Ferraro L; Tripoli G; La Cascia C; Quigley H; Quattrone A; Jongsma HE; Del Peschio S; Gatto G; ; Gayer-Anderson C; Jones PB; Kirkbride JB; La Barbera D; Tarricone I; Berardi D; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Tortelli A; Velthorst E; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Sham PC; Cardno AG; Vassos E; van Os J; Morgan C; Reininghaus U; Lewis CM; Murray RM; Di Forti M
Psychol Med; 2021 Jun; 51(8):1329-1337. PubMed ID: 32183927
[TBL] [Abstract][Full Text] [Related]
39. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
Nkam I; Langlois-Thery S; Dollfus S; Petit M
Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
[TBL] [Abstract][Full Text] [Related]
40. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia.
Fenton WS; McGlashan TH
Am J Psychiatry; 1994 Mar; 151(3):351-6. PubMed ID: 7906493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
